Abstract
In recent years, data have been accumulated regarding risk factors for metastatic potential and have improved the understanding of the pathways and frequency of lymphatic dissemination. Proper application of this information allows individualization of treatment to obtain optimal cure rates with minimum morbidity in patients with vulvar malignancy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
